Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis (JUMP)

This study has been completed.
Sponsor:
Collaborator:
Batten Disease Support and Research Assocation (BDSRA)
Information provided by (Responsible Party):
Erika Augustine, University of Rochester
ClinicalTrials.gov Identifier:
NCT01399047
First received: July 5, 2011
Last updated: December 4, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):